Welcome to our dedicated page for Trulieve Cannabis SEC filings (Ticker: TRLV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Trulieve Cannabis's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Trulieve Cannabis's regulatory disclosures and financial reporting.
Trulieve Cannabis Corp. Chairman and CEO Kim A. Rivers reported open-market sales of 482,196 Subordinate Voting Shares. These sales occurred on June 17, 18 and 22, 2026 at weighted average prices around $9.35–$9.46 per share under transaction code S.
The filing notes these transactions were effected pursuant to a Rule 10b5-1 plan to sell 2.5 million shares adopted on March 16, 2026, with a Form 144 covering a first tranche of 1,699,007 Subordinate Voting Shares filed on June 17, 2026. Following the reported sales, Rivers directly holds 2,693,724 Subordinate Voting Shares.
She also has Multiple Voting Shares convertible into 15,166,700 Subordinate Voting Shares directly and 986,700 Subordinate Voting Shares indirectly through Traunch IV LLC, as disclosed in the derivative holdings and related footnotes.
Wilson Davis submitted a Form 144 notice relating to proposed sales of Subordinate Voting Shares of Trulieve Cannabis Corp. The filing lists multiple grant dates and share lots tied to RSU award agreements and a merger agreement, including several specific share amounts and dates.
The excerpt shows RSU-related lots such as 19,700 shares (12/29/2022), 44,354 shares (12/29/2023), 1,439,662 shares (09/17/2024), and others; additional lots include 59,301, 19,765, 98,289, and 17,936 with their respective award dates. The filer is identified at an address in Salt Lake City and the exchange listed is NYSE.